The influence of glaucoma medications on ocular surface disease in primary open-angle glaucoma patients with and without conjunctivochalasis.
Department of Ophthalmology, School of Medicine, Hacettepe University, Ankara, Turkey.
Sibel
S
Kocabeyoglu
Mehmet C
MC
Mocan
Murat
M
Irkec
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003229:Conjunctival Diseases / Q000150:complications*; D003316:Corneal Diseases / Q000139:chemically induced* / Q000175:diagnosis; D015352:Dry Eye Syndromes / Q000139:chemically induced* / Q000175:diagnosis; D005141:Eyelid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011446:Prospective Studies; D011465:Prostaglandins, Synthetic / Q000009:adverse effects / Q000627:therapeutic use; D011795:Surveys and Questionnaires
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D011465:Prostaglandins, Synthetic